-
E-mail
info@z-dream.cn
-
Phone
19916533110
-
Address
Building 1, No. 139 Xuanqiu Road, Pudong New Area, Shanghai
Shanghai Zimeng Technology Co., Ltd
info@z-dream.cn
19916533110
Building 1, No. 139 Xuanqiu Road, Pudong New Area, Shanghai
Zimeng - Conference Invitation:2025 Drug Quality Control and Inspection Technology Conference
With the full implementation of the 2025 edition of the Chinese Pharmacopoeia, the quality management system of drug laboratories in China will be optimized and improved based on the specifications and standards of the new Pharmacopoeia. The new version of the Pharmacopoeia has been revised and upgraded in many ways in terms of drug quality control, testing methods, production processes, etc., further aligning with international standards, and demonstrating the scientific, progressiveness and rigorous nature of China's drug supervision.
To assist pharmaceutical companies, drug testing institutions, and inspection technicians in timely understanding the core content and latest requirements of the new pharmacopoeia, improving drug inspection technology capabilities, and ensuring drug quality and safety,YuAugust 21st to 22ndInChangsha Xiaoxiang Huatian Hotelconvene“2025 Drug Quality Control and Inspection Technology Conference”.
Against the backdrop of high-quality development in the pharmaceutical industry and continuous upgrading of drug standards, the promulgation and implementation of the 2025 edition of the Pharmacopoeia of the People's Republic of China marks a new stage in China's drug quality control. The new version of the Pharmacopoeia further optimizes its scientificity, progressiveness and practicability, adds a number of testing requirements and technical specifications, and puts forward higher goals for the quality control of drugs throughout their life cycle.
The conference will invite experts from drug testing institutes in Beijing, Guangdong, Zhejiang, Jiangxi, Hunan, Hubei and other provinces and cities to attend and give presentations, focusing on in-depth interpretation and discussion of the core revision content of the 2025 Pharmacopoeia, cutting-edge advances in testing technology, and drug quality control. Through various forms such as expert lectures, case analysis, and interactive communication, we aim to assist participants in comprehensively improving their drug quality management capabilities and familiarizing themselves with advanced testing technologies.
Welcome colleagues engaged in quality management, inspection and testing, and drug analysis research in the pharmaceutical field to the venue!

Zimeng Technology's booth will set up an on-site sample testing experience area for attendeescustomerSamples can be carried for on-site testing, and the technical team will provide guidance on the pain points of drug quality control under the new pharmacopoeia, from instrument selection to method developmentend-to-end processParticle size, fine particlesSolution.
1.Upgrading of Particle Size and Shape Analysis Technology
New PharmacopoeiaCP0982Stricter standards have been proposed for particle size control of topical preparations.ZML310The particle size analyzer for external preparations adopts high resolutionCCDLinear sensors and optical scanning platforms can automatically capture particle images and analyze particle size distribution, shape features, and surface color.
The deviceSolved the industry pain points of cumbersome operation and poor reproducibility of traditional microscopy methods, through“One click operation”Realize automated testing that meets pharmacopoeia requirements and significantly improve quality control efficiency.
2.Breakthrough in complex formulation detection
For injectable emulsions such as fat emulsions, the new pharmacopoeia clearly requiresLarge milk particle detection.ZM-02Photoresist emulsion distribution measuring instrumentIt is precisely for this purpose that precise determination of emulsions can be achieved5μmto50μmThe ratio of the total volume of droplets between them to the total volume of the oil phase.
This instrument complies withDual requirements of the Chinese and American PharmacopoeiasEnsure data compliance for enterprises in international applications.
The implementation of the 2025 edition of the Pharmacopoeia is an important milestone in the improvement of drug quality in China.8moon21sun to22Day, inChangsha Xiaoxiang Huatian HotelZimeng Technology looks forward to exploring quality control solutions under the new pharmacopoeia regulations with you.
Zimeng Technology in MedicinegranularityAfter years of deep cultivation in the field of analysis, we have always adhered to the corporate spirit of "integrity, practicality, and innovative development", and created every instrument with the concept of craftsmanship.